Title of article :
Inhibition of leukotriene B4 production in murine macrophages by lactic acid bacteria
Author/Authors :
Chise and Kimoto-Nira، نويسنده , , Hiromi and Suzuki، نويسنده , , Chise and Kobayashi، نويسنده , , Miho and Sasaki، نويسنده , , Keisuke and Mizumachi، نويسنده , , Koko، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2009
Abstract :
Leukotriene B4 (LTB4) is a lipid mediator associated with innate immune function. LTB4 is produced mainly by polymorphonuclear leukocytes and macrophages and plays important roles in host defense. However, LTB4 is also associated with inflammation, and excessive production of LTB4 can result in inflammation, allergic reactions, and carcinogenesis. Regulation of excessive LTB4 production may therefore assist in controlling these conditions. In this study, we investigated the capacity of 7 strains of lactic acid bacteria to inhibit LTB4 production by the murine macrophage cell line J774.1. All strains tested inhibited calcium ionophore (A23187)-stimulated LTB4 production in macrophages, but to varying extents. Lactobacillus helveticus Bc-10 exhibited the highest level of inhibitory activity. The inhibitory activity of strain Bc-10 was sustained after heat-killing and was observed in the intracellular cell-free extract prepared from this strain. This is the first report that intact lactic acid bacteria and their isolated cellular components can directly inhibit LTB4 production by macrophages, and provides a useful method to screen the inhibitory activity of lactic acid bacteria. This study also highlights the potential of the strain Bc-10 as a treatment option for the regulation of LTB4 production in vivo.
Keywords :
lactic acid bacteria , macrophages , Leukotriene B4 , Probiotics , inflammatory bowel disease
Journal title :
International Journal of Food Microbiology
Journal title :
International Journal of Food Microbiology